NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FORMOTEROL FUMARATE | FORMOTEROL FUMARATE DIHYDRATE | Mylan Pharmaceuticals Inc. | 6c1a6c53-af85-4220-9ce3-2373e0928f7f | 2020-12-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Fluvastatin Sodium | FLUVASTATIN | Mylan Pharmaceuticals Inc. | d0a7247c-5d83-4bc1-840f-c58314d14195 | 2020-08-20 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | f3c4f7ed-e667-4528-a675-b032c2a4425d | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Timolol Maleate | TIMOLOL MALEATE | Mylan Pharmaceuticals Inc. | 57c62928-63d8-4505-9b9e-c085a3a12c95 | 2020-07-06 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Eletriptan Hydrobromide | ELETRIPTAN HYDROBROMIDE | Mylan Pharmaceuticals Inc. | 20276f5c-f2d6-469f-9a1b-aa254a1db21c | 2020-04-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Levalbuterol | LEVALBUTEROL | Mylan Pharmaceuticals Inc. | 5b4fa89e-aa46-4504-a275-246f3b4df1df | 2020-02-17 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Levalbuterol | LEVALBUTEROL | Mylan Pharmaceuticals Inc. | 206bbdec-04f0-40e3-a259-32fc6bce20d8 | 2019-11-11 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Metolazone | METOLAZONE | Mylan Pharmaceuticals Inc. | 6639d111-eb21-4997-b964-f5c61bc088f2 | 2019-10-01 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Penciclovir | PENCICLOVIR | Mylan Pharmaceuticals Inc. | 9cb88c28-d9c9-45e3-b4fe-083327f122de | 2019-09-04 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Halcinonide | HALCINONIDE | Mylan Pharmaceuticals Inc. | b7d78c72-a683-4208-b7dd-5523502c036c | 2019-08-30 | Adverse reactions | Mylan Pharmaceuticals Inc. |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Mylan Pharmaceuticals Inc. | 23c05e9a-9df5-4978-8831-cf562aa4ba92 | 2018-12-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Denavir | PENCICLOVIR | Mylan Pharmaceuticals Inc. | 61229829-55a0-4d6f-a423-4b48a2b4d8e5 | 2018-11-26 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Mylan Pharmaceuticals Inc. | ca60a4d5-ace7-4889-94ee-e2265fd63811 | 2018-11-14 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Armodafinil | ARMODAFINIL | Mylan Pharmaceuticals Inc. | de0799f7-7644-4057-a7da-75436f978c61 | 2018-09-17 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| VUSION | MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM | Mylan Pharmaceuticals Inc. | b44b452d-3630-4cb5-8ed1-1f8edac4690c | 2018-08-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| VUSION | MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM | Mylan Pharmaceuticals Inc. | b026bc7d-3a18-41e8-88c4-1e063cd2f42c | 2018-08-14 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Mylan Pharmaceuticals Inc. | 75178670-aa57-45f9-94d5-efcf8305e683 | 2018-03-20 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| PRUDOXIN | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ca53346b-8ab3-4722-98f6-cf272706d3fa | 2017-06-29 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.